[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-gilead-sciences-yeztugo-revenue-is-set-to-jump-400-heres-what-comes-next-FR":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":259,"relatedPosts":267,"suggestedPosts":346},{"id":224,"title":225,"date":226,"modified":227,"excerpt":228,"content":229,"wordCount":230,"lang":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":239,"editor":245,"categories":250,"relatedPosts":256,"seo":257},95594,"Le chiffre d'affaires du Yeztugo de Gilead Sciences va bondir de 400 % : Voici ce qui va suivre","2026-03-03T20:00:00","2026-03-03T16:14:41","\u003Cp>Le chiffre d'affaires du Yeztugo devrait passer de 150 millions de dollars à 800 millions de dollars en une seule année, et avec l'acquisition d'Arcellx pour 7,8 milliards de dollars au deuxième trimestre, l'histoire de la croissance de Gilead ne fait que commencer.\u003C\u002Fp>\n","\n\u003Ch3 class=\"wp-block-heading\" id=\"h-key-stats-for-gilead-science-stock\">Statistiques clés pour l'action Gilead Science\u003C\u002Fh3>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Performance de la semaine écoulée : \u003C\u002Fstrong>-1,6\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Fourchette de 52 semaines : \u003C\u002Fstrong> 93,4 $ à 157,3\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Prix actuel : \u003C\u002Fstrong> 150\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>La plupart des investisseurs ne savent jamais si une action est réellement sous-évaluée ou surévaluée. Les outils d'évaluation de qualité professionnelle de TIKR vous donnent une réponse claire et étayée par des données sur plus de 60 000 actions, et ce gratuitement →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-happened\">\u003Cstrong>Que s'est-il passé ?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Gilead Sciences\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=29002&tid=2615242&ref=tikrblog\">(GILD\u003C\u002Fa>) n'est plus seulement une franchise VIH - son expansion commerciale simultanée dans les domaines de l'oncologie, des maladies du foie et de la prévention de nouvelle génération se traduit enfin dans les chiffres, avec des actions à 150 dollars.\u003C\u002Fp>\n\n\n\n\u003Cp>Le 23 février, Gilead a annoncé l'acquisition d'Arcellx pour un montant de 7,8 milliards de dollars, avec une prime de 79 %. Mizuho maintient sa note \"Outperform\" et un objectif de prix de 170 dollars, arguant que l'anito-cel a une efficacité comparable, voire supérieure, à celle de Carvykti.\u003C\u002Fp>\n\n\n\n\u003Cp>La part de marché de Biktarvy aux États-Unis a dépassé 52 %, tandis que Yeztugo a atteint une couverture de 90 % des payeurs avant son objectif d'un an, avec des prévisions de croissance de 6 % pour le VIH sur l'ensemble de l'année 2026, ancrant la base à l'approche de la décision de la FDA concernant l'anito-cel, le 23 décembre.\u003C\u002Fp>\n\n\n\n\u003Cp>Au-delà du VIH, la conviction de la Bourse s'élargit, avec 17 notations d'achat et un objectif de prix moyen de 156,59 $ au 2 mars, reflétant le fait que les analystes récompensent l'exécution dans trois domaines thérapeutiques plutôt que dans une franchise dominante.\u003C\u002Fp>\n\n\n\n\u003Cp>Johanna Mercier, Chief Commercial and Corporate Affairs Officer, a déclaré lors de la conférence téléphonique sur les résultats du quatrième trimestre que \"nous prévoyons des revenus d'environ 800 millions de dollars pour l'année 2026 pour le Yeztugo, contre 150 millions de dollars en 2025\", juste avant le lancement de la campagne de vente directe aux consommateurs prévue par l'entreprise.\u003C\u002Fp>\n\n\n\n\u003Cp>Avec aucune perte majeure d'exclusivité avant 2036, jusqu'à 10 lancements jusqu'en 2027 et un objectif de prix TIKR de 194,88 $ impliquant un rendement total de 29,9 %, Gilead est en train de construire une base de revenus multi-produits durable qui justifie un multiple structurellement plus élevé au cours des trois à cinq prochaines années.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Découvrez le moment exact où Wall Street revalorise un titre avant que le reste du marché ne le fasse - suivez les changements de notation des analystes en temps réel avec TIKR gratuitement →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-wall-street-s-take-on-gilead-sciences-stock\">\u003Cstrong>L'opinion de Wall Street sur l'action Gilead Sciences\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>L'acquisition d'Arcellx par Gilead, pour un montant de 7,8 milliards de dollars, intervient précisément au moment où l'expansion commerciale multifrontale de la société passe de la promesse à l'exécution, tirant directement vers le haut les revenus de l'oncologie que les analystes n'avaient pas entièrement pris en compte dans les estimations prévisionnelles.\u003C\u002Fp>\n\n\n\n\u003Cp>Le moteur fondamental soutient cette confiance, avec un chiffre d'affaires de 29,4 milliards de dollars pour l'exercice 2025 et un BPA normalisé en hausse de 76,4 % à 8,15 dollars, tandis que le consensus prévoit une nouvelle croissance de 6,6 % du BPA à 8,68 dollars en 2026.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"840\" height=\"566\" data-public-id=\"images\u002Fimage-62_9559614a86\u002Fimage-62_9559614a86.png\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_840,h_566,c_scale\u002Ff_webp,q_auto\u002Fv1772553864\u002Fimages\u002Fimage-62_9559614a86\u002Fimage-62_9559614a86.png?_i=AA\" alt=\"gilead sciences stock\" class=\"wp-post-95594 wp-image-95596\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1772553864\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1772553864\u002Fimages\u002Fimage-62_9559614a86\u002Fimage-62_9559614a86.png?_i=AA 840w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_202,c_scale\u002Ff_webp,q_auto\u002Fv1772553864\u002Fimages\u002Fimage-62_9559614a86\u002Fimage-62_9559614a86.png?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_517,c_scale\u002Ff_webp,q_auto\u002Fv1772553864\u002Fimages\u002Fimage-62_9559614a86\u002Fimage-62_9559614a86.png?_i=AA 768w\" sizes=\"auto, (max-width: 840px) 100vw, 840px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Cibles des analystes pour l'action GILD \u003Cstrong>(\u003C\u002Fstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>TIKR\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>)\u003C\u002Fstrong>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Wall Street indique actuellement 17 achats, 5 surperformances, et seulement 7 conservations en date du 2 mars, avec un objectif de prix moyen de 156,59 $ impliquant une hausse d'environ 4,4 % par rapport à 150,03 $, reflétant le fait que les analystes mettent à niveau la force plutôt que de poursuivre le momentum.\u003C\u002Fp>\n\n\n\n\u003Cp>La fourchette cible s'étend de 118 dollars au plus bas à 177 dollars au plus haut, la décision de la FDA concernant Anito-cel en décembre déterminant la trajectoire et un rejet ou un retard poussant les actions vers le plancher.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-does-the-valuation-model-say\">\u003Cstrong>Que dit le modèle de valorisation ?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg width=\"1024\" height=\"834\" data-public-id=\"images\u002FGILD_valuation_model_955977f71a\u002FGILD_valuation_model_955977f71a.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_834,c_scale\u002Ff_webp,q_auto\u002Fv1772553906\u002Fimages\u002FGILD_valuation_model_955977f71a\u002FGILD_valuation_model_955977f71a.webp?_i=AA\" alt=\"gilead sciences stock\" class=\"wp-post-95594 wp-image-95597\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1772553906\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_834,c_scale\u002Ff_webp,q_auto\u002Fv1772553906\u002Fimages\u002FGILD_valuation_model_955977f71a\u002FGILD_valuation_model_955977f71a.webp?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_244,c_scale\u002Ff_webp,q_auto\u002Fv1772553906\u002Fimages\u002FGILD_valuation_model_955977f71a\u002FGILD_valuation_model_955977f71a.webp?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_626,c_scale\u002Ff_webp,q_auto\u002Fv1772553906\u002Fimages\u002FGILD_valuation_model_955977f71a\u002FGILD_valuation_model_955977f71a.webp?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1536,h_1251,c_scale\u002Ff_webp,q_auto\u002Fv1772553906\u002Fimages\u002FGILD_valuation_model_955977f71a\u002FGILD_valuation_model_955977f71a.webp?_i=AA 1536w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2048,h_1669,c_scale\u002Ff_webp,q_auto\u002Fv1772553906\u002Fimages\u002FGILD_valuation_model_955977f71a\u002FGILD_valuation_model_955977f71a.webp?_i=AA 2048w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_978,c_scale\u002Ff_webp,q_auto\u002Fv1772553906\u002Fimages\u002FGILD_valuation_model_955977f71a\u002FGILD_valuation_model_955977f71a.webp?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_1141,c_scale\u002Ff_webp,q_auto\u002Fv1772553906\u002Fimages\u002FGILD_valuation_model_955977f71a\u002FGILD_valuation_model_955977f71a.webp?_i=AA 1400w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Résultats du modèle d'évaluation de l'action GILD \u003Cstrong>(\u003C\u002Fstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=21127&tid=2621295&ref=tikrblog\">\u003Cstrong>TIKR\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>)\u003C\u002Fstrong>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Le modèle d'évaluation TIKR fixe un objectif intermédiaire de 194,88 $ par rapport au cours actuel de 150,03 $, projetant un rendement total de 29,9 % sur 4,8 ans, soit un taux de rendement interne annualisé de 5,6 %.\u003C\u002Fp>\n\n\n\n\u003Cp>Le marché semble sous-évaluer le redressement des marges de Gilead, car les marges EBIT devraient augmenter à 47 % en 2026, après un creux de 29,6 % en 2024.\u003C\u002Fp>\n\n\n\n\u003Cp>Cette reprise n'est donc pas spéculative - la marge d'exploitation non GAAP de l'exercice 2025 a déjà atteint 45 %, ce qui confirme la discipline structurelle en matière de coûts qui sous-tend l'estimation prévisionnelle.\u003C\u002Fp>\n\n\n\n\u003Cp>Les prévisions de la direction de $800M pour Yeztugo en 2026 contre $150M en 2025 indiquent une inflexion de la franchise que le consensus n'a pas encore entièrement récompensée dans le multiple.\u003C\u002Fp>\n\n\n\n\u003Cp>Cependant, le déclin continu de Veklury vers une prévision de $600M en 2026 et tout échec dans l'approbation de l'anito-cel pourraient comprimer le BPA à court terme et retarder la revalorisation que le modèle suppose.\u003C\u002Fp>\n\n\n\n\u003Cp>La décision de la FDA du 23 décembre sur l'anito-cel dans le myélome multiple de quatrième ligne est l'événement unique qui valide ou bloque toute la thèse de l'augmentation en oncologie.\u003C\u002Fp>\n\n\n\n\u003Cp>Gilead est sous-évalué à 150,03 $ compte tenu d'un objectif moyen de 194,88 $ et d'une inflexion du pipeline que le multiple actuel ne reflète pas encore ; surveillez la décision relative à l'anito-cel.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Les meilleures idées de Wall Street ne restent pas cachées longtemps. Surveillez les révisions d'analystes, les résultats supérieurs aux attentes et les surprises en matière de chiffre d'affaires sur des milliers d'actions dès qu'elles se produisent avec TIKR gratuitement →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-should-you-invest-in-gilead-sciences-inc\">\u003Cstrong>Devriez-vous investir dans Gilead Sciences, Inc.\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>La seule façon de le savoir est de consulter les chiffres vous-même. TIKR vous donne un accès gratuit aux mêmes données financières de qualité institutionnelle que celles utilisées par les analystes professionnels pour répondre à cette question.\u003C\u002Fp>\n\n\n\n\u003Cp>En consultant l'action GILD, vous verrez des années de données financières historiques, les prévisions des analystes de Wall Street en matière de revenus et de bénéfices pour les trimestres à venir, l'évolution des multiples de valorisation au fil du temps et la tendance à la hausse ou à la baisse des objectifs de prix.\u003C\u002Fp>\n\n\n\n\u003Cp>Vous pouvez créer une liste de surveillance gratuite pour suivre Gilead Sciences, Inc. en même temps que toutes les autres actions qui vous intéressent. Aucune carte de crédit n'est nécessaire. Juste les données dont vous avez besoin pour décider par vous-même.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Accédez gratuitement à des outils professionnels pour analyser l'action GILD sur TIKR →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n",801,"fr","\u002Fblog\u002Fgilead-sciences-yeztugo-revenue-is-set-to-jump-400-heres-what-comes-next","gilead-sciences-yeztugo-revenue-is-set-to-jump-400-heres-what-comes-next","images\u002FFEATURED-IMAGE-MAKER-393\u002FFEATURED-IMAGE-MAKER-393","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1772554449\u002Fimages\u002FFEATURED-IMAGE-MAKER-393\u002FFEATURED-IMAGE-MAKER-393.png?_i=AA",{"altText":237,"imageCredit":238},"Gilead Sciences’ Yeztugo Revenue Is Set to Jump 400%: Here’s What Comes Next","TIKR",{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":244},"Gian Estrada","giantikr","author","",[],{"name":246,"slug":247,"role":248,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":249},"Thomas Richmond","thomastikr","editor",[],[251],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},"Examens des Actions","reviews","\u002Fblog\u002Fcategory\u002Freviews",0,[],{"title":237,"metaDesc":258,"opengraphDescription":258,"twitterTitle":237,"twitterDescription":258},"Yeztugo revenue is projected to surge from $150M to $800M in a single year, and with a $7.8B Arcellx acquisition closing in Q2, Gilead’s growth story is just getting started.",{"title":260,"description":261,"twitterTitle":260,"twitterDescription":261,"author":240,"articlePublisher":262,"articlePublishedTime":226,"articleModifiedTime":227,"twitterLabel1":263,"twitterData1":264,"ogTitle":260,"ogDescription":261,"ogUrl":232,"ogImage":235,"ogImageWidth":265,"ogImageHeight":266,"ogImageSecureUrl":235,"ogImageAlt":237,"twitterImage":235},"Gilead Sciences’ Yeztugo Revenue Is Set to Jump 400%: Here’s What Comes Next","Yeztugo revenue is projected to surge from $150M to $800M in a single year, and with a $7.8B Arcellx acquisition closing in Q2, Gilead’s growth story is just getting started.","TIKR.com","Temps de lecture estimé","6 minutes",1200,630,[268,285,300,315,331],{"id":255,"title":269,"date":270,"excerpt":271,"wordCount":272,"uri":273,"slug":274,"cloudinaryAssetId":275,"featuredImageOriginalUrl":276,"featuredImageMetadata":277,"author":278,"categories":282,"relatedPosts":284},"Merck est en hausse de 42 % au cours des 6 derniers mois. Voici ce que l'action pourrait devenir en 2026","2026-03-03 19:35:00","L'action Merck a progressé de 42 % au cours des six derniers mois, et notre analyse suggère que le titre pourrait encore offrir une hausse significative jusqu'en 2026. Voici pourquoi la durabilité de l'oncologie, l'élan du pipeline et le soutien institutionnel constant continuent de soutenir la configuration.",705,"\u002Fblog\u002Fmerck-is-up-42-in-the-last-6-months-heres-where-the-stock-could-head-in-2026","merck-is-up-42-in-the-last-6-months-heres-where-the-stock-could-head-in-2026","images\u002F@TrueCreatives-via-Canva-123\u002F@TrueCreatives-via-Canva-123","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772556024\u002Fimages\u002F@TrueCreatives-via-Canva-123\u002F@TrueCreatives-via-Canva-123.png?_i=AA",{"altText":269},{"name":279,"slug":280,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":281},"Nikko Henson","nikkotikr",[],[283],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":286,"date":287,"excerpt":288,"wordCount":289,"uri":290,"slug":291,"cloudinaryAssetId":292,"featuredImageOriginalUrl":293,"featuredImageMetadata":294,"author":295,"categories":297,"relatedPosts":299},"LyondellBasell est en hausse de 28 % depuis le début de l'année. Voici où les actions pourraient aller en 2026","2026-03-03 19:05:00","L'action LyondellBasell est en hausse de 28 % depuis le début de l'année en 2026, car le resserrement des stocks de polyéthylène et la forte génération de liquidités soutiennent l'idée d'un rebond. Voici pourquoi le redressement des marges et la discipline en matière d'approvisionnement pourraient encore entraîner une hausse significative par rapport aux niveaux actuels.",790,"\u002Fblog\u002Flyondellbasell-is-up-28-year-to-date-heres-where-shares-could-go-in-2026","lyondellbasell-is-up-28-year-to-date-heres-where-shares-could-go-in-2026","images\u002F@Stas_V-from-Getty-Images-via-Canva-213\u002F@Stas_V-from-Getty-Images-via-Canva-213","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772552857\u002Fimages\u002F@Stas_V-from-Getty-Images-via-Canva-213\u002F@Stas_V-from-Getty-Images-via-Canva-213.png?_i=AA",{"altText":286},{"name":279,"slug":280,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":296},[],[298],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":301,"date":302,"excerpt":303,"wordCount":304,"uri":305,"slug":306,"cloudinaryAssetId":307,"featuredImageOriginalUrl":308,"featuredImageMetadata":309,"author":310,"categories":312,"relatedPosts":314},"L'action GE Healthcare à 80$ : Pourquoi les analystes voient une hausse de 35 % ?","2026-03-03 19:00:00","GEHC vient d'obtenir l'autorisation de la FDA pour trois systèmes d'IRM et de conclure une nouvelle facilité de crédit de 500 millions de dollars, mais le véritable catalyseur, à savoir l'autorisation de Photonova et l'augmentation de la dose de Flyrcado, n'a pas encore eu lieu.",761,"\u002Fblog\u002Fge-healthcare-stock-at-80-why-analysts-see-35-upside","ge-healthcare-stock-at-80-why-analysts-see-35-upside","images\u002FFEATURED-IMAGE-MAKER-392\u002FFEATURED-IMAGE-MAKER-392","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1772545982\u002Fimages\u002FFEATURED-IMAGE-MAKER-392\u002FFEATURED-IMAGE-MAKER-392.png?_i=AA",{"altText":301},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":311},[],[313],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":316,"date":302,"excerpt":317,"wordCount":318,"uri":319,"slug":320,"cloudinaryAssetId":321,"featuredImageOriginalUrl":322,"featuredImageMetadata":323,"author":324,"categories":328,"relatedPosts":330},"L'action RCUS bondit de 17,5 % malgré une perte nette de 353 millions de dollars : ce que la juste valeur de 34 $ indique","Voici pourquoi l'action d'Arcus Biosciences a bondi de 17,5 % pour atteindre 24 dollars, les données cliniques et une trésorerie de 981 millions de dollars ayant compensé les pertes croissantes.",660,"\u002Fblog\u002Frcus-stock-jumps-17-5-despite-353m-net-loss-what-34-fair-value-signals","rcus-stock-jumps-17-5-despite-353m-net-loss-what-34-fair-value-signals","images\u002FRCUS-stock\u002FRCUS-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772563814\u002Fimages\u002FRCUS-stock\u002FRCUS-stock.png?_i=AA",{"altText":316},{"name":325,"slug":326,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":327},"Rexielyn Diaz","rexietikr",[],[329],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":332,"date":333,"excerpt":334,"wordCount":335,"uri":336,"slug":337,"cloudinaryAssetId":338,"featuredImageOriginalUrl":339,"featuredImageMetadata":340,"author":341,"categories":343,"relatedPosts":345},"L'action AXT bondit de 22% à 46 dollars : pourquoi les analystes voient toujours une juste valeur de 27 dollars","2026-03-03 18:50:00","Voici pourquoi l'action AXT a bondi de 22,2 % pour atteindre 46 $, les investisseurs regardant au-delà des faibles marges et vers une croissance prévue de 42 % du chiffre d'affaires.",674,"\u002Fblog\u002Faxt-stock-surges-22-to-46-why-analysts-still-see-27-fair-value","axt-stock-surges-22-to-46-why-analysts-still-see-27-fair-value","images\u002FAXTI-stock\u002FAXTI-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772562833\u002Fimages\u002FAXTI-stock\u002FAXTI-stock.png?_i=AA",{"altText":332},{"name":325,"slug":326,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":342},[],[344],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],[347,367,382,397,414,429,447,461,476,490],{"id":255,"title":348,"date":349,"excerpt":350,"wordCount":351,"uri":352,"slug":353,"cloudinaryAssetId":354,"featuredImageOriginalUrl":355,"featuredImageMetadata":356,"author":357,"categories":361,"relatedPosts":366},"Barclays ramène la note de l'action Blue Owl à \"Equal Weight\" alors que la chute du cours de l'action se poursuit","2026-03-03 11:59:00","Barclays abaisse la note de Blue Owl Capital en raison d'un fort ralentissement des entrées de capitaux dans les BDC non cotées et d'une forte augmentation des rachats. L'action a baissé de 50 % au cours de l'année écoulée en raison des craintes liées au crédit.",775,"\u002Fblog\u002Fbarclays-cuts-blue-owl-nyse-owl-stock-rating-equal-weight-price-plunge","barclays-cuts-blue-owl-nyse-owl-stock-rating-equal-weight-price-plunge","images\u002FOWL-stock-1\u002FOWL-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772533744\u002Fimages\u002FOWL-stock-1\u002FOWL-stock-1.png?_i=AA",{"altText":348},{"name":358,"slug":359,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":360},"Aditya Raghunath","adityatikr",[],[362],{"name":363,"slug":364,"uri":365,"description":243,"postsCount":255},"Investissement Général","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",[],{"id":255,"title":368,"date":369,"excerpt":370,"wordCount":371,"uri":372,"slug":373,"cloudinaryAssetId":374,"featuredImageOriginalUrl":375,"featuredImageMetadata":376,"author":377,"categories":379,"relatedPosts":381},"L'action Novo Nordisk atteint son plus bas niveau en 52 semaines, Goldman Sachs la rétrograde à \"neutre\".","2026-03-03 10:55:00","L'action Block a augmenté de plus de 20 % après que la société fintech a annoncé qu'elle allait licencier plus de 4 000 employés, soit environ la moitié de ses effectifs.",655,"\u002Fblog\u002Fnovo-nordisk-nyse-nvo-stock-hits-52-week-low-as-goldman-sachs-downgrades-it-to-neutral","novo-nordisk-nyse-nvo-stock-hits-52-week-low-as-goldman-sachs-downgrades-it-to-neutral","images\u002FNVO-stock_954941bea1\u002FNVO-stock_954941bea1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772532602\u002Fimages\u002FNVO-stock_954941bea1\u002FNVO-stock_954941bea1.png?_i=AA",{"altText":368},{"name":358,"slug":359,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":378},[],[380],{"name":363,"slug":364,"uri":365,"description":243,"postsCount":255},[],{"id":255,"title":383,"date":384,"excerpt":385,"wordCount":386,"uri":387,"slug":388,"cloudinaryAssetId":389,"featuredImageOriginalUrl":390,"featuredImageMetadata":391,"author":392,"categories":394,"relatedPosts":396},"Le financement massif d'OpenAI déclenche la chute des actions d'Amazon","2026-03-02 10:30:00","L'action d'Amazon a chuté après la levée de fonds de 110 milliards de dollars d'OpenAI, malgré l'engagement d'Amazon à hauteur de 50 milliards de dollars et la conclusion d'un accord de partenariat majeur avec AWS.",831,"\u002Fblog\u002Fopenai-massive-funding-round-triggers-selloff-in-amazon-nasdaq-amzn-stock","openai-massive-funding-round-triggers-selloff-in-amazon-nasdaq-amzn-stock","images\u002FAMZN-stock-1\u002FAMZN-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772278707\u002Fimages\u002FAMZN-stock-1\u002FAMZN-stock-1.png?_i=AA",{"altText":383},{"name":358,"slug":359,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":393},[],[395],{"name":363,"slug":364,"uri":365,"description":243,"postsCount":255},[],{"id":255,"title":398,"date":399,"excerpt":400,"wordCount":401,"uri":402,"slug":403,"cloudinaryAssetId":404,"featuredImageOriginalUrl":405,"featuredImageMetadata":406,"author":407,"categories":411,"relatedPosts":413},"L'action Chime bondit de 14 % sur la voie de la rentabilité selon les GAAP : voici où l'action pourrait se diriger en 2026","2026-03-01 15:00:00","Les actions de Chime Financial (CHYM) sont en train d'enregistrer une forte hausse après la publication de leurs résultats, suite à la publication d'un rapport sur le quatrième trimestre qui a fait date.",743,"\u002Fblog\u002Fchime-stock-surges-14-on-path-to-gaap-profitability-heres-where-the-stock-could-be-headed-in-2026","chime-stock-surges-14-on-path-to-gaap-profitability-heres-where-the-stock-could-be-headed-in-2026","images\u002F21-2\u002F21-2","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772322176\u002Fimages\u002F21-2\u002F21-2.png?_i=AA",{"altText":398},{"name":408,"slug":409,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":410},"Wiltone Asuncion","wiltonetikr",[],[412],{"name":363,"slug":364,"uri":365,"description":243,"postsCount":255},[],{"id":255,"title":415,"date":416,"excerpt":417,"wordCount":418,"uri":419,"slug":420,"cloudinaryAssetId":421,"featuredImageOriginalUrl":422,"featuredImageMetadata":423,"author":424,"categories":426,"relatedPosts":428},"L'action de Crescent Energy bondit de 7 % grâce à des synergies doublées dans le Permien : Voici où l'action pourrait aller en 2026","2026-03-01 14:50:00","Crescent Energy Company (CRGY) aborde l'année 2026 en tant qu'opérateur multi-bassins à grande échelle, après avoir réalisé des transactions d'une valeur de près de 5 milliards de dollars. ",816,"\u002Fblog\u002Fcrescent-energy-stock-surges-7-on-doubled-permian-synergies-heres-where-the-stock-could-go-in-2026","crescent-energy-stock-surges-7-on-doubled-permian-synergies-heres-where-the-stock-could-go-in-2026","images\u002F20-2\u002F20-2","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772322164\u002Fimages\u002F20-2\u002F20-2.png?_i=AA",{"altText":415},{"name":408,"slug":409,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":425},[],[427],{"name":363,"slug":364,"uri":365,"description":243,"postsCount":255},[],{"id":255,"title":430,"date":431,"excerpt":432,"wordCount":433,"uri":434,"slug":435,"cloudinaryAssetId":436,"featuredImageOriginalUrl":437,"featuredImageMetadata":438,"author":439,"categories":441,"relatedPosts":446},"En baisse de 25 % par rapport à son plus haut niveau historique, l'action Capital One peut-elle offrir de meilleurs rendements en 2026 ?","2026-03-03 11:25:00","L'action Capital One pourrait générer des rendements de 30 % d'ici 2028, l'intégration de Discover et l'acquisition de Brex débloquant la croissance du réseau de paiements et l'expansion des services bancaires aux entreprises.",1309,"\u002Fblog\u002Fdown-25-from-all-time-high-can-capital-one-nyse-stock-deliver-better-returns-in-2026","down-25-from-all-time-high-can-capital-one-nyse-stock-deliver-better-returns-in-2026","images\u002FCOF-stock\u002FCOF-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772516734\u002Fimages\u002FCOF-stock\u002FCOF-stock.png?_i=AA",{"altText":430},{"name":358,"slug":359,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":440},[],[442],{"name":443,"slug":444,"uri":445,"description":243,"postsCount":255},"Évaluation","valuation","\u002Fblog\u002Fcategory\u002Fvaluation",[],{"id":255,"title":448,"date":369,"excerpt":449,"wordCount":450,"uri":451,"slug":452,"cloudinaryAssetId":453,"featuredImageOriginalUrl":454,"featuredImageMetadata":455,"author":456,"categories":458,"relatedPosts":460},"En hausse de 20 % au cours des 12 derniers mois, l'action Synchrony Financial peut-elle évoluer à la hausse en 2026 ?","En hausse de 20% sur 12 mois, Synchrony Financial est prometteur avec la croissance du partenariat avec Walmart. Notre modèle prévoit une hausse de 27 % à 87 $ d'ici décembre 2028. Analyse à l'intérieur.",1261,"\u002Fblog\u002Fup-20-in-last-12-months-can-synchrony-financial-syf-stock-deliver-further-in-2026","up-20-in-last-12-months-can-synchrony-financial-syf-stock-deliver-further-in-2026","images\u002FSYF-stock\u002FSYF-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772512295\u002Fimages\u002FSYF-stock\u002FSYF-stock.png?_i=AA",{"altText":448},{"name":358,"slug":359,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":457},[],[459],{"name":443,"slug":444,"uri":445,"description":243,"postsCount":255},[],{"id":255,"title":462,"date":463,"excerpt":464,"wordCount":465,"uri":466,"slug":467,"cloudinaryAssetId":468,"featuredImageOriginalUrl":469,"featuredImageMetadata":470,"author":471,"categories":473,"relatedPosts":475},"En hausse de 42 % en 3 ans, l'action de Raymond James Financial peut-elle continuer à progresser ?","2026-03-03 09:55:00","L'action Raymond James a baissé de 10 % en 12 mois. Un fort recrutement, 31 milliards de dollars de nouveaux actifs nets signalent une reprise. Notre modèle prévoit une hausse de 21 % pour atteindre 185 $ d'ici septembre 2028.",1234,"\u002Fblog\u002Fup-42-in-3-years-can-raymond-james-financial-nyse-rjf-stock-deliver-further","up-42-in-3-years-can-raymond-james-financial-nyse-rjf-stock-deliver-further","images\u002FRJF-stock_9542509878\u002FRJF-stock_9542509878","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772467602\u002Fimages\u002FRJF-stock_9542509878\u002FRJF-stock_9542509878.png?_i=AA",{"altText":462},{"name":358,"slug":359,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":472},[],[474],{"name":443,"slug":444,"uri":445,"description":243,"postsCount":255},[],{"id":255,"title":477,"date":463,"excerpt":478,"wordCount":479,"uri":480,"slug":481,"cloudinaryAssetId":482,"featuredImageOriginalUrl":483,"featuredImageMetadata":484,"author":485,"categories":487,"relatedPosts":489},"En hausse de 19 % au cours des 12 derniers mois, les valeurs financières régionales peuvent-elles encore progresser en 2026 ?","Des bénéfices solides au quatrième trimestre et un taux de rendement des capitaux propres de 18 % placent Regions Financial en position de croissance. Notre modèle prévoit une hausse de 26 % pour atteindre 35 $ d'ici 2028. L'action RF peut-elle tenir ses promesses en 2026 ?",1264,"\u002Fblog\u002Fup-19-in-last-12-months-can-regional-financial-nyse-stock-deliver-better-returns-in-2026","up-19-in-last-12-months-can-regional-financial-nyse-stock-deliver-better-returns-in-2026","images\u002FRF-stock_953648bd63\u002FRF-stock_953648bd63","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772446487\u002Fimages\u002FRF-stock_953648bd63\u002FRF-stock_953648bd63.png?_i=AA",{"altText":477},{"name":358,"slug":359,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":486},[],[488],{"name":443,"slug":444,"uri":445,"description":243,"postsCount":255},[],{"id":255,"title":491,"date":492,"excerpt":493,"wordCount":494,"uri":495,"slug":496,"cloudinaryAssetId":497,"featuredImageOriginalUrl":498,"featuredImageMetadata":499,"author":500,"categories":502,"relatedPosts":504},"En baisse de 65 % par rapport à son plus haut niveau historique, l'action Brown-Forman peut-elle offrir de meilleurs résultats en 2026 ?","2026-03-03 09:45:00","L'action Brown-Forman pourrait atteindre 36 dollars d'ici 2028 grâce au succès du Blackberry de Jack Daniel et à la croissance des marchés émergents, malgré des vents contraires à court terme dans le secteur de la consommation.",1334,"\u002Fblog\u002Fdown-65-from-all-time-high-can-brown-forman-nyse-stock-deliver-better-results-in-2026","down-65-from-all-time-high-can-brown-forman-nyse-stock-deliver-better-results-in-2026","images\u002FBFB-stock\u002FBFB-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772433508\u002Fimages\u002FBFB-stock\u002FBFB-stock.png?_i=AA",{"altText":491},{"name":358,"slug":359,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":501},[],[503],{"name":443,"slug":444,"uri":445,"description":243,"postsCount":255},[]]